Abstract

Turning Point will report Q2 2026 results on August 04, 2026 Pre-Market.

Market Forecast

Based on company guidance fields and current quarter forecasts, Turning Point’s Q2 2026 revenue is projected at 129.22 million US dollars with a year-over-year increase of 22.14%, EBIT at 16.47 million with a year-over-year decrease of 25.67%, and forecast EPS of 0.43 with a year-over-year decrease of 47.24%. The implied setup suggests pressure on margins and earnings as mix and costs offset top-line growth, with adjusted EPS tracking lower year over year.

The company’s main business remains dominated by smoke-free products and traditional smoking products. The segment with the strongest near-term potential is smoke-free products.

Last Quarter Review

Turning Point’s last reported quarter delivered revenue of 124.28 million US dollars, a gross profit margin of 54.95%, GAAP net profit attributable to the parent company of 11.67 million US dollars, a net profit margin of 9.39%, and adjusted EPS of 0.76, with year-over-year growth of 16.76% for revenue and a year-over-year decline of 16.48% for adjusted EPS. Quarter on quarter, net profit grew 42.11%.

A key highlight was better-than-expected top-line performance versus prior estimates alongside healthy gross margin support. By business, smoke-free products contributed 87.61 million US dollars and smoking products contributed 36.67 million US dollars.

Current Quarter Outlook (with major analytical insights)

Main business trajectory

Revenue growth remains anchored by the company’s core portfolio across smoke-free and conventional products, with guidance pointing to a 129.22 million US dollars top line in Q2 2026, up 22.14% year over year. Forecast EBIT of 16.47 million and EPS of 0.43 imply margin compression relative to the prior-year quarter, which could reflect higher input costs, promotional intensity, or an unfavorable revenue mix. The company’s ability to preserve gross spread while defending market share will be central to stabilizing profitability. Monitoring sell-through, shelf velocities, and any price/mix actions will be important to gauge the sustainability of revenue growth as underlying category trends evolve.

Most promising business focus

Smoke-free products remain the largest and most scalable revenue driver, contributing 87.61 million US dollars in the prior quarter. The forecast narrative implies that this category should continue to underpin overall growth as the portfolio broadens and distribution deepens. However, with forecast EPS down 47.24% year over year despite revenue growth, investors will watch whether incremental investment, promotional spend, or category competition is weighing on the contribution margin from this segment. Execution around innovation cadence and channel strategy is likely to determine whether smoke-free can accelerate operating leverage into the back half of the year.

Stock price sensitivity factors this quarter

The stock is likely to react to signs of margin stabilization versus the forecasted EBIT decline trajectory. A print that shows better-than-expected gross profit margin resilience relative to the revenue beat potential would likely be taken positively by the market. Conversely, higher-than-anticipated SG&A or promotions that suppress flow-through could reinforce the forecasted EPS decline and weigh on sentiment. Management color on inventory levels, pricing discipline, and category elasticity will be important swing factors for post-print performance.

Analyst Opinions

Bullish views account for the majority of recent commentary, emphasizing continued revenue expansion led by smoke-free product strength and resilience in core categories despite forecasted margin pressure. Analysts highlight that last quarter’s revenue outperformance relative to estimates, combined with a robust gross profit margin baseline of 54.95%, provides a buffer for earnings even as EPS normalizes. The constructive stance also points to the positive quarter-on-quarter net profit acceleration of 42.11% as a signal of operational momentum. Investors inclined toward the bullish case expect that, if management demonstrates disciplined spending and improved mix in smoke-free offerings, the company can outperform the mid-teen EBIT outlook and narrow the EPS gap versus prior-year levels into the second half of 2026.